The complexities surrounding the SARS-CoV-2 virus, responsible for COVID-19, appear to be unceasing. As we continue our endeavors to map out its effects, we’re reminded that its implications are not confined to respiratory distress. A recent revelation funded by the National Institutes of Health (NIH) unveils its ability to directly infiltrate the heart’s arteries, instigating a potential domino effect of cardiovascular issues.
Atherosclerosis
Direct effect on Heart’s Arteries
Table of Contents
This NIH-backed study has spotlighted an alarming feature of SARS-CoV-2: its proclivity to infect the coronary arteries. Upon doing so, inflammation in the arterial plaque, or fatty buildup, intensifies. This inflammation stands as a precursor to severe repercussions like heart attacks and strokes.
For clarity, one must grasp that this vulnerability is especially pronounced in elderly individuals harboring atherosclerotic plaque. However, what makes this finding universally crucial is that irrespective of one’s plaque quantities, the virus exhibits a capability to colonize and multiply within these arteries. This accentuates the concern to encompass even those with minimal arterial plaque.
Our body’s primary line of defense against such invasions is deploying macrophages, specific white blood cells. In arterial contexts, apart from fending off invaders, these cells bear the responsibility of cholesterol expulsion. But, a saturation of cholesterol can metamorphose them into ‘foam cells’. This research propounds that SARS-CoV-2 may catalyze this transformation, escalating inflammation in any pre-existing plaque.
Adding another layer to this intricate mechanism, infected macrophages and foam cells discharge cytokines—molecules intensifying inflammation. This, in turn, can bolster plaque accumulation, sketching a grim scenario for those contracting the virus, notably if they already grapple with cardiovascular maladies.
Expert Insight
Our Dr. Tampiwa Chebani here at Gilmore Health, shared his insights: “With SARS-CoV-2, the narrative keeps evolving. Though predominantly tagged as a respiratory virus, its ramifications evidently seep into crucial bodily systems, inclusive of the cardiovascular.” He further articulated, “The revelation that coronary arteries aren’t immune to its grasp can indeed refine our perspective on the virus’s long-term repercussions.”
It’s imperative to note that these findings bolster the necessity of a panoramic approach in tackling COVID-19. Respiratory symptomatology is only one facet; potential cardiovascular ramifications cannot be sidelined, especially when considering vulnerable populations.
Final Thoughts
Echoing Dr. Tampiwa’s sentiments, each research endeavor elucidates a fragment more about this enigmatic virus. Recognizing SARS-CoV-2’s potential to compromise coronary arteries fortifies the understanding of its intricacy and the continual efforts to demystify it. As the pandemic narrative unfolds, it’s evident that novel challenges will perpetually surface. Nonetheless, with unwavering research vigor and collaboration, we remain optimistic about evolving treatments and prophylactic strategies.
References
Eberhardt, N., Noval, M.G., Kaur, R. et al. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Nat Cardiovasc Res (2023). https://doi.org/10.1038/s44161-023-00336-5
FEEDBACK:
